BALAXI PHARMACEUTICALS
Back to All Ratios
|
BALAXI PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| PCE(x) | 24.23 | 13.09 | -1,872.75 | 11.32 | 7.30 |
What is the latest Price to Cash Earnings (PCE) ratio of BALAXI PHARMACEUTICALS ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2026 | 24.23 |
| Mar2025 | 13.09 |
| Mar2024 | -1,872.75 |
| Mar2023 | 11.32 |
| Mar2022 | 7.30 |
How is Price to Cash Earnings (PCE) of BALAXI PHARMACEUTICALS Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2026 | 24.23 | 85.10 | |
| Mar2025 | 13.09 | Positive | |
| Mar2024 | -1872.75 | Negative | |
| Mar2023 | 11.32 | 55.07 | |
| Mar2022 | 7.3 | - | |
Other Financial Ratios of BALAXI PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹121.8 Cr | -2.7% | -0.3% | -41.4% | Stock Analytics | |
| ADANI ENTERPRISES | ₹360,090.0 Cr | -1.7% | -1.5% | 16.9% | Stock Analytics | |
| ADITYA INFOTECH | ₹48,635.1 Cr | -6.2% | -3.5% | 176.4% | Stock Analytics | |
| AEGIS LOGISTICS | ₹43,071.2 Cr | 0.1% | -13% | 56.7% | Stock Analytics | |
| PREMIER ENERGIES | ₹37,398.8 Cr | -6.9% | -9.5% | -12.7% | Stock Analytics | |
| REDINGTON | ₹26,639.0 Cr | 3.7% | -13.1% | 21.3% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -2.7% |
-0.3% |
-41.4% |
| SENSEX | 1.4% |
12.8% |
-1.7% |
You may also like the below Video Courses